1. Concurrence of malignant fibrohistiocytoma and Takayasu arteritis: a case report.
- Author
-
Du JF, Chen JW, Li F, Tian J, Xie X, and Mao N
- Subjects
- Adult, Biopsy, Chemotherapy, Adjuvant, Colectomy, Colonic Neoplasms diagnosis, Colonic Neoplasms immunology, Colonic Neoplasms pathology, Colonic Neoplasms therapy, Endoscopy, Gastrointestinal, Fatal Outcome, Female, Glucocorticoids therapeutic use, Histiocytoma, Malignant Fibrous diagnosis, Histiocytoma, Malignant Fibrous immunology, Histiocytoma, Malignant Fibrous secondary, Histiocytoma, Malignant Fibrous therapy, Humans, Immunohistochemistry, Intestinal Obstruction etiology, Lung Neoplasms secondary, Takayasu Arteritis diagnosis, Takayasu Arteritis drug therapy, Takayasu Arteritis immunology, Tomography, X-Ray Computed, Treatment Outcome, Colonic Neoplasms complications, Histiocytoma, Malignant Fibrous complications, Takayasu Arteritis complications
- Abstract
Takayasu arteritis (TA) is a type of systemic large-vessel vasculitis that usually affects the aorta and its major branches. It remains unrecognized owing to delayed diagnosis (Boltin et al. in Rheumatol Int 27(10):985-987, 2007) and non-characteristic clinical features. It has been described in association with many autoimmune diseases, such as inflammatory digestive tract diseases. However, report of TA associated with tumors, especially malignant tumors, are rare. We here presented a case diagnosed by both Takayasu arteritis and malignant fibrous histiocytoma, from which we learned not only clinical lessons, but also consensus of relationships between these two diseases.
- Published
- 2012
- Full Text
- View/download PDF